Icahn School of Medicine at Mount Sinai
Videos
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Sequencing Immunotherapy for Myeloma"
FEATURING
Samir Parekh
- 162 views
- June 25, 2024
- 2
Icahn School of Medicine at Mount Sinai
Navigating aGVHD Treatment: Integrating Recent Updates in Clinical Management
FEATURING
James Ferrara
- 33 views
- May 31, 2024
Icahn School of Medicine at Mount Sinai
Leveraging Liquid Biopsy in Lung Cancer
FEATURING
Christian Rolfo
- 45 views
- May 22, 2024
Icahn School of Medicine at Mount Sinai
PanRAF Inhibitors in NSCLC
FEATURING
Rajwanth Veluswamy
- 1 view
- May 7, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implications"
FEATURING
Douglas Tremblay
- 383 views
- January 26, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Outcomes After CAR-T in MM Patients With Extramedullary and Paramedullary Disease"
FEATURING
Darren Pan
- 41 views
- December 22, 2023
Insights from 2023 ASH Annual Meeting
Multiple Myeloma: Inflammatory Biomarkers and Outcomes CAR T-Cell Therapy
FEATURING
Darren Pan
- 63 views
- December 22, 2023
Insights from 2023 ASH Annual Meeting
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis
FEATURING
Douglas Tremblay
- 370 views
- December 13, 2023
Insights from 2023 IMS Annual Meeting
IMS 2023 Insights: "Highlights From the International Myeloma Society Annual Meeting"
FEATURING
Joshua Richter
- 349 views
- October 10, 2023
- 1
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
FEATURING
Douglas Tremblay
- 787 views
- September 29, 2023
- 4
Icahn School of Medicine at Mount Sinai
Managing the Nonreproductive Comorbidities of Polycycstic Ovary Syndrome
FEATURING
Andrea Dunaif
- 745 views
- July 31, 2023
- 9
Icahn School of Medicine at Mount Sinai
Multiple Myeloma: Adverse Effects of CAR-T
FEATURING
Sridevi Rajeeve
- 263 views
- May 24, 2023
- 1
Icahn School of Medicine at Mount Sinai
Leveraging SCLC Subtypes and Other Biomarkers
FEATURING
Fred Hirsch
- 273 views
- May 18, 2023
- 3
Yale Cancer Center
Myeloma in 2023: So Many Drugs, Yet So Few Cures
FEATURING
Ajai Chari
- 517 views
- May 9, 2023
- 3
Icahn School of Medicine at Mount Sinai
Overview of JAKARTA & JAKARTA2 Trials: Impact of Fedratinib on Spleen Volume and MF Symptoms
FEATURING
Julian Waksal
- 263 views
- May 9, 2023
- 1
Icahn School of Medicine at Mount Sinai
What's the Difference? Covalent vs. Non-Covalent BTKis in MCL
FEATURING
Joshua Brody
- 53 views
- April 5, 2023
- 1
Icahn School of Medicine at Mount Sinai
Myelofibrosis Treatment Options Beyond the JAK/STAT Pathway
FEATURING
Marina Kremyanskaya
- 800 views
- April 3, 2023
- 2
Icahn School of Medicine at Mount Sinai
Kidney Week 2022: Cell-to-Cell Chats in the Diabetic Kidney Endothelial Cells to Podocytes and Back
FEATURING
Ilse Daehn
- 102 views
- March 15, 2023
Oliver Van Oekelen
Outcomes of MM Pts Progressing After BCMA-Targeted CAR T-Cell Therapy
- 71 views
- January 4, 2023
- 1
ASH 2022 Conference Coverage
ASH 2022 Neurotoxicity With Motor Symptoms After BCMA-Directed CAR-T Therapy in MM
FEATURING
Samir Parekh
- 67 views
- December 16, 2022
- 1
SABCS 2022 Conference Coverage
SABCS 2022 Predictors of Response to Neoadjuvant Chemo in Breast Cancer: OncotypeDX vs. MammaPrint vs. Liquid Biopsy
FEATURING
Nadeem Bilani
- 520 views
- December 15, 2022
- 4
Icahn School of Medicine at Mount Sinai
TKI in the Management of Advanced HCC
FEATURING
Augusto Villanueva
- 223 views
- July 7, 2022
Icahn School of Medicine at Mount Sinai
Symptom Assessments in Myelofibrosis and How to Examine the Spleen
FEATURING
Marina Kremyanskaya
- 65 views
- June 2, 2022
Icahn School of Medicine at Mount Sinai
Triplet Regimens in Early Relapse MM: Evolving Treatment Dynamics
FEATURING
Cesar Rodriguez
- 118 views
- April 18, 2022